After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

A menacing 50-degree slope and 9,000 feet straight down: that’s the terrain American mountaineer Jim Morrison tackled when he became the first person to ski the most difficult route on Everest, the ...

RXRX has upcoming data in H2'25 from the TUPELO trial of REC-4881 in familial adenomatous polyposis. The company will also report data from the ELUCIDATE trial of REC-617 in H2'25. A previous update ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

The modern internet is ruled by algorithms. When you boot up Instagram, for example, what you see in your feed is strategically sorted by the app's AI based on your past activity to keep you engaged ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.

Researchers at FIU’s College of Engineering and Computing have developed an encryption algorithm to defend videos from attackers with access to the world's most powerful computers. The encryption ...

Think about the last time you opened Netflix. Did you scroll through countless options or go with a recommended title? When you log into social media, do you decide what to see, or does an algorithm ...

You might have heard that algorithms are in control of everything you hear, read, and see. They control the next song on your Spotify playlist, or what YouTube suggests you watch after you finish a ...